4 Medication Error Prevention Across the Care Process

Medication use as a safety process

Medication safety depends on reliable safeguards throughout the medication-use process, not on expecting any one person to be perfect. A medication error may be intercepted before it reaches the patient and does not always cause injury. An adverse drug event is harm associated with medication use; it may occur with or without an error.

Errors can occur during prescribing, transcribing, dispensing, administration, or monitoring. Failures at more than one step may combine, so prevention requires safeguards across the whole process.

Safeguards at each stage

Prescribing

Before ordering, confirm the indication, patient, allergies, relevant diagnoses, and current medications. Consider patient-specific factors such as age, weight, kidney or liver function, and pregnancy status when relevant. Select an appropriate drug, dose, route, frequency, and duration; avoid unnecessary therapy and check for interactions, duplicate therapy, contraindications, and required monitoring.

Make orders clear and complete. Standardized electronic prescribing and decision support can help, but alerts need thoughtful review because excessive low-value alerts can contribute to alert fatigue. Clarify the intent of high-risk or unusual orders instead of relying on assumptions. If a verbal or telephone order is necessary, use a structured communication process and read back the medication, dose, route, and frequency for confirmation.

Transcribing and communicating orders

Transcribing means transferring an order or medication information between people or systems. Handwriting, abbreviations, decimal-point errors, incomplete handoffs, and copied-forward lists can introduce discrepancies. Electronic orders can reduce some transcription problems but do not eliminate wrong selections, incorrect data entry, or communication failures.

Use standardized names, units, and dose formats, and avoid unsafe abbreviations. Make changes visible and time-stamped. Communicate the reason for important medication starts, changes, holds, and discontinuations. At handoffs, identify who is responsible for follow-up, including pending tests and medication monitoring.

Dispensing

Pharmacists and pharmacy staff help verify that the selected product, strength, dosage form, quantity, directions, and label match the intended order. Screening should account for allergies, interactions, duplicate therapy, and patient-specific concerns. Standardized storage, separation of products that could be confused, clear labeling, and well-designed workflows can reduce selection and preparation errors.

Administration

Before giving a medication, confirm the patient’s identity and compare the medication with the current order and the patient’s clinical condition. Check the drug, dose, route, timing, and relevant administration instructions. These checks are often summarized as the “rights” of medication administration; they are useful prompts, not a complete safety system.

Use barcode medication administration as designed and investigate mismatches rather than bypassing them. Smart infusion pumps and standardized concentrations can add protection for infusions, but they require appropriate setup and maintenance. Reduce avoidable interruptions during preparation and administration, and document promptly and accurately. If a dose is refused, omitted, delayed, or held, record the reason and communicate it when clinically important.

Monitoring

Safe use continues after a medication is given. Monitor for the intended response, side effects, toxicity, interactions, and adherence using laboratory tests, vital signs, symptoms, or other measures appropriate to the drug and patient. Define who will review results, when follow-up is due, and what action is needed for an abnormal result. Anticoagulants and insulin require attention to both treatment effect and potential harm; the specific checks depend on the medication and clinical situation.

High-risk and easily confused medications

High-alert medications can cause especially serious harm if used in error; their defining feature is potential harm severity, not necessarily a higher frequency of errors. Examples commonly included in acute-care safety lists are insulin, anticoagulants, opioids, concentrated electrolytes, and neuromuscular blocking agents. Relevant lists vary by care setting, so organizations should select safeguards suited to their services and risks.

Useful safeguards include standardized ordering and concentrations, clear labeling, restricted access where appropriate, appropriate clinical decision support, and reliable monitoring. Independent double checks may be useful for selected medications or steps. Applying them to everything can become a ritual rather than a meaningful safeguard; when used, a second check should be genuinely independent and should complement, not replace, stronger system design.

LASA medications have names that appear or sound similar, or packaging that can be confused. A wrong-product error can occur during prescribing, electronic-menu selection, verbal communication, storage, or dispensing. Safeguards include checking the full drug name and indication, displaying the generic name alongside the brand when appropriate, and separating high-risk name pairs. Tall Man lettering emphasizes differences in selected names, as in vinBLAStine and vinCRIStine. It is an aid, not a substitute for independent verification, and FDA recommendations apply to specific name pairs.

Technology and medication transitions

Medication technology can support a closed-loop process by linking the order, pharmacy verification, medication administration record, patient identification, and monitoring. Computerized prescribing, decision support, barcodes, and smart pumps can intercept particular errors, but technology can also introduce risks through poor configuration, confusing screens, incomplete data, alert overload, or workarounds. Review system performance and make it easy for staff to report technology-related hazards.

Medication reconciliation is especially important at admission, transfer, and discharge. Obtain and verify the best possible medication history, compare it with new orders, and resolve unintended differences. Ask patients or caregivers how medicines are actually taken, rather than relying only on an electronic list. Include prescriptions, over-the-counter medicines, vitamins, supplements, and other relevant products.

Document intentional changes and communicate an accurate, updated list to the patient and next care team. A shared, current medication list can help prevent omissions, duplications, and unintended dose changes.

Partnering with patients and caregivers

Patients and caregivers are partners in prevention. Encourage them to keep an updated medication list, bring medication containers or a reliable list to visits, ask what each new or changed medicine is for and how to take it, and report unexpected effects or discrepancies.

Use plain language and confirm understanding. Adapt communication to the patient’s language, health literacy, access, and abilities. A patient’s concern that a medicine, dose, or schedule seems different can reveal a discrepancy. Patient participation strengthens professional verification but does not replace it.

Learning and improving the system

Treat a medication error or near miss as an opportunity to improve the system. Encourage timely reporting and examine conditions that made the event possible, such as workflow, staffing, labeling, storage, communication, technology, training, or unclear responsibility. A systems approach looks beyond individual blame to identify conditions that may put other patients at risk.

Prospective process reviews can help identify hazards before harm occurs; retrospective review can clarify how an event unfolded. Quality-improvement cycles can test and refine changes. For example, a team concerned about insulin-order discrepancies might map the ordering and administration process, test a clearer order set on one unit, study near misses and staff feedback, and adapt the change before broader use.

Track outcomes, such as medication-related harm; processes, such as completion of medication reconciliation; and balancing measures, such as delays or unintended workflow burden. Repeat the Plan, Do, Study, Act cycle to continue testing and refining improvements.